CU Anschutz Cancer Center

A Guide to Imaging Technologies that Revolutionized How Cancer is Diagnosed and Treated Radiologist Dulcy Wolverton, MD, says tools using x-rays, sound, magnets, radio waves, and computers have 'changed everything.'

X-ray, mammography, PET, MRI, and ultrasound are among the tools that have changed how cancer is detected and treated. Radiologist Dulcy Wolverton, MD, explains these technologies ⬇️
https://news.cuanschutz.edu/cancer-center/wolverton-diagnostic-imaging

Meet Tin Tin Su, PhD | From Burma to Leading Change in Science YouTube video by University of Colorado Anschutz Cancer Center

By synthesizing insights across her team, she guides thoughtful, evidence-based decisions and fosters an environment that drives innovation and discovery.

Watch the full interview here: youtu.be/U1KjNDA7eRs

Collaboration is at the core of Tin Tin Su, PhD’s leadership. She brings together multidisciplinary teams where diverse perspectives are valued and every voice is encouraged.

Multi-Omics Analysis Reveals New Pathway for Therapy Resistance in Pediatric Medulloblastoma Analyzing paired original and relapsed tumor samples, researchers found genomic differences linked to treatment resistance for medulloblastoma.

Why do some pediatric brain tumors come back after treatment?@cucancercenter.bsky.social researchers and pediatric oncologist Dr. Rajeev Vibhakar identified a new pathway behind therapy resistance that points to future treatment options. #OncSky #PediatricOncology

Read more: https://bit.ly/4u13K6O

On a black background with a photo cutout of Natalie Serkova, PhD. In CU gold "Natalie Serkova, PhD, 2026 Excellence In Leadership Award".

⭐ Celebrating excellence at CU Anschutz: Congratulations to cancer center's Natalie Serkova, PhD, for receiving the 2026 Excellence in Leadership Award! 🎉

A photo of Rob Mahedy at a small cabin in Crested Butte, Colorado.

“You realize how much people really want to help — it helps people to help others.”

Mountaineer Rob Mahedy found a new sense of community through his bladder cancer journey: https://bit.ly/4smnMH4

Another reminder: voting ends soon!

A photo cut out of Melanie Joy, PharmD, PhD, overlayed on a blurred background of campus. Her name is listed in black text above more text that reads "David and Nancy Lamb Endowed Chair in Pharmacy Innovation and Entrepreneurship". There is CU black and gold triangles on each end of the graphic. The bottom is a white rectangle.

Congrats to Melanie Joy, PharmD, PhD, for being named the newly established David and Nancy Lamb Endowed Chair in Pharmacy Innovation and Entrepreneurship under the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences! 🎉

Full announcement: https://bit.ly/4bpYT6H

A graphic with a background of the Denver skyline during a sunset. In dark blue text "Cancer Updates GI and Lung" over a white transparent square. Smaller text "Denver Marriott Westminster, 7000 Church Ranch Blvd Westminster, CO, 80021. Free Registration for All Healthcare Providers. In-Person Access Only!" Then there is photos of Sunnie Kim, MD, and Tejas Patil, MD, with their titles.

This Cancer Updates Conference features educational activities designed to address the needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in treating gastrointestinal and lung cancers.

RSVP for free: https://bit.ly/4u3nTZJ

Carlin Callaway, DNP, RN, speaking after receiving the Hearts & Hope Epic Hero Award at the 2026 Hearts & Hope Gala Presented by Epic Experience.

Carlin Callaway, DNP, RN, speaking after receiving the Hearts & Hope Epic Hero Award at the 2026 Hearts & Hope Gala Presented by Epic Experience.

On 2/28, Carlin Callaway, DNP, RN, was officially named this year’s Hearts & Hope Epic Hero Award recipient! Congratulations! 🎉

Powerful blog by our Comms Cttee chair Michelle Springer, MS, CGC!

👍for providers wanting to learn ⏫ abt the role of 🧬 testing & its critical role in identifying these risks early incl for #HereditaryGICancer helping pts & 👪 access tailored screening, prevention & treatment strategies. Read it 👇

A photo of Andi Dwyer, MPH, on campus, she is smiling. In black text towards the bottom "The Importance of Colorectal Cancer Screening" followed by smaller text over a CU gold rectangle "With Andrea (Andi) Dwyer, MPH, program director of the Colorado Cancer Screening Program (CCSP)".

In a CU gold rectangle in black text "The Colorado Cancer Screening Program Fights Colorectal Cancer Locally:" Then there is a quote from Andi: "Our program aims to reduce disparities in access to cancer screening among Colorado communities, focused on support for rural health centers and safety-net clinics and hospitals,” In another but smaller CU gold rectangle towards the bottom of the graphic "Andi and CCSP Senior Manager, Elsa Staples, MPH, review the current Colorado Cancer Plan." There is a cutout of Andi and Elsa looking over a piece of paper, the current Colorado Cancer Plan.

In black text "With Cancer, Cardiovascular, and Pulmonary Disease (CCPD) grants totalling $2M, the CCSP team will continue their work at least until the summer of 2028. With community partners, the team is also expanding the network to lung, esophageal, and gastric cancer screening." Towards the bottom there is a CU gold grid with a gap in the middle. In the middle is a CU gold award icon.

Over a CU gold rectangle in black text "Colorectal cancer facts to remember:" followed by a list over the white background "Colorectal cancer is preventable and highly curable when diagnosed and treated early. Individuals with a family history of adenomatous polyps or colorectal cancer should consider starting screening before the age of 45. There are over 100 colorectal cancer clinical trials currently being offered by cancer center members, giving patients many different treatment options. "

Andi Dwyer, MPH, and the Colorado Cancer Screening Program (CCSP) aim to create and expand access to colorectal cancer screening in Colorado and across the nation.

For Colorectal Cancer Awareness Month, read more about CCSP: https://bit.ly/4aSeQC2

What Genetic Testing Can Reveal about Hereditary Cancer Conditions Inherited genetic mutations that can cause cancer are mostly rare, but they can greatly increase cancer risk, says a certified genetic counselor.

Rare Disease Day: Inherited genetic mutations that can cause cancer are mostly rare, but they can greatly increase cancer risk, says certified genetic counselor Michelle Springer, MS, CGC ⬇️
https://news.cuanschutz.edu/cancer-center/springer-rare-disease-hereditary-cancer-conditions

How Are State-Run Psilocybin Therapy Programs Going? How are the first state-run psilocybin therapy programs going? Plus, psilocybin clinical trials for cancer patients dealing with anxiety.

Cancer center leader Stacy Fischer, MD, talks co-leading the largest US clinical trial on psilocybin use for anxiety in advanced cancer patients on this @scifri.bsky.social episode. Listen here ⬇️
https://www.sciencefriday.com/segments/psilocybin-therapy-industry-clinical-trials

In CU gold text with a shadow: "U.S. News & World Report Hospital Rankings." In black italicized text: "Board-certified physicians and registered members of Doximity are eligible to participate in voting." In bold black text: "Voting ends mid March." All the text is indented to the left side. The CU Anschutz Cancer Center is on the bottom left. The right side of the graphic has CU gold horizontal line and diagonal grid in CU gold on a photo of a stethoscope on a table during a doctor visit.

Voting is now open for the U.S. News & World Report hospital rankings! 🏥 ✅

Board-certified physicians and registered Doximity, learn how to vote here: https://news.cuanschutz.edu/medicine/voting-for-u.s.-news-world-report-hospitals-ranking

The graphic is mostly CU gray with a white grid in the background. In center over the white grid is a CU gold frame with a photo of a doctor pointing with a pen at a diagram of a bile duct. There is a green ribbon in the corner of this frame as well, representing Ballgladder and Bile Duct Cancer Awareness.

For Gallbladder and Bile Duct Cancer Awareness Month, Lindsey Davis, MD, explains the cancer center's bile duct cancer clinical trials that are focusing on perioperative chemotherapy and targeted therapy drugs: https://bit.ly/3MxpSVr

In the center image, there is three cutouts of Gina Bouchard, PhD, Kristine Erlandson, MD, MSC, and Heide L. Ford, PhD, holding awards. In black text "Congratulations!" is above. Below also in black text over two triangles of CU gold "2026 CU Anschutz Cancer Center Research Award Recipients"

Gina Bouchard, PhD, receiving her award. In a CU gold rectangle in black text "Rising Star Research Award - Basic Science Gina Bouchard, PhD"

Kristine Erlandson, MD, MSC, receiving her award. In a CU gold rectangle in black text "Research Mentor Award Kristine Erlandson, MD, MSC"

Heide L. Ford, PhD, receiving her award. In a CU gold rectangle in black text "Chancellors Distinguished Research Leadership Award - Basic Science Heide L. Ford, PhD"

Congrats to our cancer center members who were honored at this week's 2026 CU Anschutz Research Awards Ceremony! 🎉

CU Anschutz Recruits National Leader to Launch Functional Personalized Medicine Initiative National leader in tumor organoids Alice Soragni, PhD, launches a rapid functional precision medicine initiative at CU Anschutz within CCPM and DBMI.

A nationally recognized leader in patient-derived tumor organoids and functional precision oncology has arrived at CU! Welcome, Alice Soragni, PhD (@alice.soragnilab.com) 👋 ⬇️
https://news.cuanschutz.edu/dbmi/alice-soragni-joins-university-colorado-anschutz

UCHealth using new technology to identify cancer cells previously missed Surgeons at UCHealth Anschutz Cancer Pavilion in Aurora are using new technology to identify cancer cells they normally would have missed.

Robert Meguid, MD, MPH, FACS, was recently featured on Denver7 discussing how pafolacianine binds to cancer cells and lights them up with fluorescent markers, helping to flag unseen tumors during lung surgeries. Check it out here: https://bit.ly/3MfwebW

A photo of Snooki on the left. There is a black rectangle with a CU gold outline behind her. There is a CU gold rectangle as well with a black outline cutting across from the right side. In black text "Jersey Shore star Nicole "Snooki" Polizzi announces Stage 1 cervical cancer diagnosis."

Snooki's cervical cancer announcement is a reminder that early detection is key and to not put off your routine doctor checkups. Learn about cervical cancer and how to prevent it: https://bit.ly/4acc3CQ

I’d never cried at a conference until today. Ross, thank you for this incredible talk. You’re a wonderful human, clinician, researcher, boss, mentor, and friend. The standing ovation was more than deserved. @drcamidge.bsky.social @cucancercenter.bsky.social #TTLC26

FDA’s Expedited Review of Drug Could Be a ‘Game Changer’ for Pancreatic Cancer The FDA is accelerating its review of a drug called daraxonrasib, which may be a more effective pancreatic cancer treatment, explains Christopher Lieu, MD.

The FDA is speeding up its review of daraxonrasib, a targeted drug therapy, to see if it may deliver better results for pancreatic cancer patients. Cancer center leader Christopher Lieu, MD, shares his insight ⬇️
https://bit.ly/4rU8wRn

In CU gold text with a shadow: "U.S. News & World Report Hospital Rankings." In black italicized text: "Board-certified physicians and registered members of Doximity are eligible to participate in voting." In bold black text: "Voting ends mid March." All the text is indented to the left side. The CU Anschutz Cancer Center is on the bottom left. The right side of the graphic has CU gold horizontal line and diagonal grid in CU gold on a photo of a stethoscope on a table during a doctor visit.

Voting is now open for the U.S. News & World Report hospital rankings! 🏥 ✅

Board-certified physicians and registered Doximity, learn how to vote here: https://news.cuanschutz.edu/medicine/voting-for-u.s.-news-world-report-hospitals-ranking

Surgeon Atsushi Oba, MD, PhD, Joins Pancreatic Program At CU Anschutz Atsushi Oba, MD, PhD, brings more than 15 years of surgical experience in Japan and a year of experience as a research associate with Marco Del Chiaro, MD.

New @cudeptsurg.bsky.social arrival Atsushi Oba, MD, PhD, who was a research associate under cancer center's Marco Del Chiaro, MD, PhD, in 2019, is passionate about conducting research looking for new biomarkers that will improve pancreatic cancer treatment ⬇️
https://bit.ly/46BJnTo

The CU Anschutz Cancer Center is one of eight hubs nationwide evaluating new multi‑cancer detection tests to determine whether they can reliably detect cancer signals in blood. 

Learn more about the Vanguard Study: cbsn.ws/4tu0YGR

Brianna Fernandez, left, and Sabrina Spencer, PhD, right. They are in the lab.

Quiescent or senescent? Cancer center member Sabrina Spencer, PhD, and PhD candidate Brianna Fernandez help identify cancer that is more likely to recur in new study: https://bit.ly/4aFKOm7

In larger white text in the top right: "Recipient of the 2026 Vilcek Prize in Biomedical Science". In the bottom right in white text in a black rectangle "Karolin Luger, PhD". Then in CU gold text is a quote from Luger: “Like many others, my lab has built on this original discovery, and we continue to be surprised by the elegant and complicated ways in which DNA access is regulated by nucleosomes. I am proud to have contributed a bit of beauty and knowledge to the world.” The background is mostly black with a CU gold triangle in the lower right. There is a photo of Luger on the right side of the graphic.

Biochemist Karolin Luger, PhD, has been awarded the 2026 Vilcek Prize in Biomedical Science for her pioneering work on nucleosomes—research that reshaped genome science and opened the door to new treatments for cancer and other diseases! 🏆

'You're Never Too Young': CU Anschutz Cancer Center Expert on James Van Der Beek’s Colorectal Cancer Actor James Van Der Beek has died, according to news media accounts February 11, 2026. This article was first published November 5, 2024, after he disclosed his colorectal cancer diagnosis.

Back in November 2024, actor James Van Der Beek announced that he had been diagnosed with colorectal cancer at age 47, highlighting that it’s not just a disease that older people need to be concerned about. Christopher Lieu, MD, tells us more about colorectal cancer ⬇️
https://bit.ly/3Z3DjQt

In a white circle that overlays a photo of CU Anschutz there is text: "5280 Top Doctors. If you have a colleague who you’d like to see included in the 2026 Top Doctors issue of the 5280 magazine, now’s your chance to make that happen! Nominations are due by 2/15". The CU Anschutz and Cancer Center logo are below the text. The background around the circle is CU gold and black lines.

The 5280 Magazine Top Doctor nominations end on 2/15. The nominations can be submitted by all licensed MDs and DOs in the Denver metro area.

Make your nominations here: https://bit.ly/4rFqTti
Nominations tutorial: https://bit.ly/3OjpE4A

Olympic Ice Dancer Piper Gilles Survived Ovarian Cancer. Here’s What to Know About the Disease. A CU Anschutz Cancer Center gynecologic oncologist explains a “silent killer” that’s the fifth most common cause of cancer death among U.S. women.

Piper Gilles is more than just an Olympic ice dancer. She's an ovarian cancer survivor. Tomorrow, when she skates in Italy, she skates cancer-free. To help bring awareness around the disease, we spoke to cancer center gynecologic oncologist Marisa Moroney, MD ⬇️
https://bit.ly/4kxB2pF